Comparative Studies on Dissolution and Bioavailability of Tamoxifen Citrate Loaded Binary and Ternary Solid Dispersions.

Shaker, Dalia S; Ghorab, Mohamed K; Teiama, Mohamed S.
Artículo en Inglés | IMSEAR | ID: sea-163357

Documentos relacionados

  1. Development of Delayed Release Oral Formulation Comprising Esomeprazole Spray Dried Dispersion Utilizing Design of Experiment As An Optimization Strategy.
  2. Soluplus<sup>®</sup> polymeric nanomicelles improve solubility of BCS-class II drugs.
  3. Effervescence-induced amorphous solid dispersions with improved drug solubility and dissolution.
  4. Development of a Novel Gastric Process Simulation Model: The Successful Assessment of Bioequivalence and Bioinequivalence of a Biopharmaceutics Classification System Class II Weak Acid Drug.
  5. Novel application of PBBM to justify impact of faster dissolution on safety and pharmacokinetics - a case study and utility in regulatory justifications.
  6. Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs.
  7. Bioequivalence Dissolution Test Criteria for Formulation Development of High Solubility-Low Permeability Drugs.
  8. Physiologically Based Biopharmaceutics Model of Vildagliptin Modified Release (MR) Tablets to Predict In Vivo Performance and Establish Clinically Relevant Dissolution Specifications.
  9. Using Tiny-TIM Dissolution and In Silico Simulation to Accelerate Oral Product Development of a BCS Class II Compound.
  10. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.